[1]
Zhang, J.; Du, F.; Peng, B.; Lu, R.; Gao, H.; Zhou, Z. Structure, electronic properties, and radical scavenging mechanisms of daidzein, genistein, formononetin, and biochanin A: A density functional study. J. Mol. Struct-THEOCH., 2010, 955(1-3), 1-6.
[2]
Zielinska, A.; Paradowska, K.; Jakowski, J.; Wawer, I. 13C CP MAS NMR and GIAO-CHF/DFT calculations of flavonoids: Morin, formononetin, tricin, genistein, formononetin and 3,7-dihydroxyflavone. J. Mol. Struct., 2008, 873(1-3), 109-116.
[3]
Wu, J.H.; Li, Q.; Wu, M.Y.; Guo, D.J.; Chen, H.L.; Chen, S.L.; Seto, S.W.; Au, A.L.; Poon, C.C.; Leung, G.P.; Lee, S.M.; Kwan, Y.W.; Chan, S.W. Formononetin, an isoflavone, relaxes rat isolated aorta through endothelium-dependent and endotheliumin dependent pathways. J. Nutr. Biochem., 2009, 21(7), 613-620.
[4]
Maurya, R.; Yadav, D.K.; Singh, G.; Bhargavan, B.; Narayana, M.P.S.; Sahai, M.; Singh, M.M. Osteogenic activity of constituents from Butea monosperma. Bioorg. Med. Chem. Lett., 2009, 19(3), 610-613.
[5]
Sun, T.; Wang, J.; Huang, L.H.; Cao, Y.X. Antihypertensive effect of formononetin through regulating the expressions of eNOS,5-HT2A/1B receptors and a1-adrenoceptors in spontaneously rat arteries. Eur. J. Pharmacol., 2013, 699(1-3), 241-249.
[6]
Huang, J.; Xie, M.; Gao, P.; Ye, Y.; Liu, Y.; Zhao, Y.; Luo, W.; Ling, Z.; Cao, Y.; Zhang, S.; Gao, F.; Tang, W. Antiproliferative effects of formononetin on human colorectal cancer via suppressing cell growth in vitro and in vivo. Process Biochem., 2015, 50(6), 912-917.
[7]
Li, Z.; Dong, X.; Zhang, J.; Zeng, G.; Zhao, H.; Liu, Y.; Qiu, R.; Mo, L.; Ye, L. Formononetin protects TBI rats against neurological lesions and the underlying mechanism. J. Neurol. Sci., 2014, 338(1-2), 112-117.
[8]
Liang, K.; Ye, Y.; Wang, Y.; Zhang, J.; Li, C. Formononetin mediates neuroprotection against cerebral ischemia/reperfusion in rats via downregulation of the Bax/Bcl-2 ratio and upregulation PI3K/Akt signaling pathway. J. Neurol. Sci., 2014, 344(1-2), 100-104.
[9]
Huh, J.E.; Nam, D.W.; Baek, Y.H.; Kang, J.W.; Park, D.S.; Choi, D.Y.; Lee, J.D. Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways. Int. Immunopharmacol., 2011, 11(1), 46-54.
[10]
Lo, Y.L.; Wang, W. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro. Chem. Biol. Interact., 2013, 205(3), 188-197.
[11]
11 Chen, C.Y.; Zu, Y.G.; Fu, Y.J.; Luo, M.; Zhao, C.J.; Wang, W.; Zhao, B.S.; Li, J.; Efferth, T. Preparation and antioxidant activity of Radix Astragali residues, extracts rich in calycosin and formononetin. Biochem. Eng. J., 2011, 56(1-2), 84-93.
[12]
Mu, H.; Bai, Y.H.; Wang, S.T.; Zhu, Z.M.; Zhang, Y.W. Research on antioxidant effects and estrogenic effect of formononetin from Trifolium pratense (red clover). Phytomedicine, 2009, 16(4), 314-319.
[13]
Ma, W.; Nomura, M.; Takahashi-Nishioka, T.; Kobayashi, S. Combined effects of fangchinoline from Stephania tetrandra Radix and formononetin and calycosin from Astragalus membranaceus Radix on hyperglycemia and hypoinsulinemia in streptozotocin-diabetic mice. Biol. Pharm. Bull., 2007, 30(11), 2079-2083.
[14]
Wang, Y.; Zhu, Y.; Gao, L.; Yin, H.; Xie, Z.; Wang, D.; Zhu, Z.; Han, X. Formononetin Attenuates IL-1β-Induced Apoptosis and NF-κB Activation in INS-1 Cells. Molecules, 2012, 17(9), 10052-10064.
[15]
Mutai, P.; Pavadai, E.; Wiid, I.; Ngwane, A.; Baker, B.; Chibale, K. Synthesis, antimycobacterial evaluation and pharmacophore modeling of analogues of the natural product formononetin. Bioorg. Med. Chem. Lett., 2015, 25(12), 2510-2513.
[16]
Auyeung, K.K.; Law, P.C.; Ko, J.K. Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft. Oncol. Rep., 2012, 28(6), 2188-2194.
[17]
ISO Guide 34. General requirements for the competence of reference
material producers. International Organization for Standardization:
Geneva, 2009.
[18]
Espinoza, M.; Olea-Azar, C.; Massiff, G.; Villa, A.E. Development of a reference material for copper and iron in wine. J. Food Compos. Anal., 2008, 21(8), 684-688.
[19]
Sin, D.W.M.; Chan, P.K.; Cheung, S.T.C.; Wong, Y.L.; Wong, S.K.; Mok, C.S.; Wong, Y.C. Development of a candidate certified reference material of cypermethrin in green tea. Anal. Chim. Acta, 2012, 721, 110-114.
[20]
ISO Guide 35. Reference materials–General and statistical principles
for certification, International Organization for Standardization:
Geneva, 2006.
[21]
Bruni, G.; Berbenni, V.; Milanese, C.; Girella, A.; Cardini, A.; Lanfranconi, S.; Marini, A. Determination of the nateglinide polymorphic purity through DSC. J. Pharmaceut. Biomed., 2011, 54(5), 1196-1199.
[22]
Gong, N.B.; Wang, X.Y.; Zhang, B.X.; Gao, Z.L.; Du, G.H.; Lv, Y. Characterization and uncertainty evaluation of a new certified reference material of Baicalein. J. Pharmaceut. Biomed., 2014, 89, 106-110.
[23]
Gong, N.B.; Liu, S.C.; Xu, W.; Shi, Y.Q.; Du, G.H.; Lu, Y. Purity assessment of luteolin reference material candidates by coulometric titration method. Anal. Methods-UK, 2013, 5, 784-788.
[24]
Tan, R.H.; An, X.H. Isolation and synthesis of formnonetin. Chem. Res. Appl., 2009, 21(5), 764-765.
[25]
Pelter, A.; Ward, R.S.; Whalley, J.L. A Facile Synthesis of 2-Substituted isoflavones for immunoassay: Assembly of the isoflavonoid skeleton by means of a novel cyclisation reaction. Synthesis-Stuttgart., 1998, 1998(12), 1793-1802.
50
2